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Obesity, type II diabetes, and hyperlipidaemia, which frequently coexist and are strongly associated with oxidative stress, increase
the risk of cardiovascular disease. An increase in carbohydrate intake, especially of fructose, and a high-fat diet are both factors
that contribute to the development of these metabolic disorders. In recent studies carried out in diabetic rats, authors reported
that Ibervillea sonorae had hypoglycaemic activity; saponins and monoglycerides present in the plant could be responsible for the
eﬀects observed. In the present study, we determined the eﬀects of an aqueous I. sonorae e x t r a c to nam u r i n em o d e lo fo b e s i t ya n d
hyperglycaemia, induced by a high-calorie diet, and the relationship of these eﬀects with hepatic oxidation. A high-fat diet over a
period of 8 weeks induced weight gain in the mice and increased triglycerides and blood glucose levels. Simultaneous treatment
with I. sonorae aqueous extracts, at doses of 100, 200, and 400mg/kg, decreased triglycerides and glycaemia levels, prevented an
increase in body weight in a dose-dependent manner, and decreased hepatic lipid oxidation at a dose of 200mg/kg. These data
suggestthattheaqueousextractfromI.sonoraerootpreventsobesity,dyslipidaemia,andhyperglycaemiainducedbyahypercaloric
diet; however, high doses may induce toxicity.
1.Introduction
Obesity is a global health problem and is associated with the
development of chronic diseases such as hyperlipidaemias,
typeIIdiabetes,andcardiovascularcomplications.Oxidative
stress is linked to obesity, and adipose tissue can produce
adipokines that induce production of reactive oxygen species
(ROS) that cause insulin resistance. All of these factors may
contribute to metabolic syndrome [1]. It is estimated that
genetic factors, high-fat diets, and sedentary lifestyles are the
main factors underlying the development of these diseases
[2, 3]. In Mexico, as in other countries, a rise in the number
of obesity cases in adults and children has been noted [4–6].
Other reports have demonstrated that high consumption of
reﬁned carbohydrates, especially fructose, can induce obesity
and hyperglycaemia, with concomitant insulin resistance
[7, 8]. The primary recommendations to manage the disease
include diet modiﬁcation and physical exercise to achieve
weight loss [9], followed by pharmacological treatment.
A variety of natural products have been proposed
as pharmacological treatments for obesity. The products
that can induce body weight reduction and prevent diet-
induced obesity in animal models include crude extracts
and compounds isolated from plants [10]. Therefore, they
have also been recommended as an aid in prevention of
obesity. Other natural products such as cinnamon [11],2 Journal of Biomedicine and Biotechnology
Table 1: Composition of the control and test diets.
Control (%)∗ HF (%)∗∗
Protein 28.05 18.23
Fat 12.14 7.89
Lard 0 35.00
Carbohydrate 59.81 38.88
Total (g) 100 100
Calories (kcal) 467.5 614.5
∗Lab Chow 5012 diet.
∗∗Fructose (60%) was administered by gavage (2.4kcal).
green tea [12], and oats [13] have demonstrated antioxidant,
hypoglycaemic, and hypolipidaemic properties. The use and
acceptance of traditional medicine have increased in recent
years [14, 15]. In traditional Mexican medicine the root of
Ibervillea sonorae (IS), colloquially known as “wareke,” is
widely used as a topical antibiotic, cathartic, antirheumatic
[16],and,recently,hypoglycaemic[17].Previouslypublished
pharmacological properties for IS root include antiviral and
antifungal [18], cytotoxic [19], and hypoglycaemic eﬀects.
Alarcon-Aguilar et al. [20] demonstrated the hypoglycaemic
action of dichloromethane-extracted IS on healthy and
aloxane-induced diabetic mice [21]; however, its hypolipi-
daemic eﬀects remain unclear. The present study evaluated
the eﬀect of the aqueous extract of IS on glucose and lipid
levels as well as hepatic oxidation in mice fed a high-fat diet
plus fructose.
2.MaterialsandMethods
2.1. Plant Material. The dried powder of Ibervillea sono-
rae (IS) root was purchased from Nutra Herbal (Mex-
ico City) (http://www.nutraherbalmexico.com/). IS sam-
ples were water extracted at 90◦C with 10g sample per
100mL water and allowed to cool at room temperature.
The extract was then ﬁltered and freeze-dried (Freeze Dry
System/Freezone 4.5, LABCONCO, USA). The extraction
yield for the resulting brown powder was 8%, and it was
stored at −20◦C until use. Doses of 100, 200, and 400mg/kg
lyophilised extract were dissolved in distilled water and
administered daily by gavage.
2.2. High-Fat Diet. The high-fat diet was prepared by adding
35% lard to a ground standard diet. Fructose (Cedrosa SA
Mexico) solution (60%) was administered daily by gavage.
Food intake was measured every day, and body weight was
measured once every two days. The composition of the diets
is shown in Table 1.
2.3. Animals. Male ICR mice (Biorepository of the National
School of Biological Sciences) weighing 25–30g were housed
in a room at a constant temperature of 22 ± 1◦Ca n da
12h light/dark cycle (lights on at 9:00 AM) and were given
food and water ad libitum. All experiments were approved
by the Laboratory Animal Care Committee of the National
SchoolofBiologicalSciences(NationalPolytechnicInstitute)
Table 2: Treatment groups.
Groups Treatment (mg/kg body weight)
1C o n t r o l
2 High fat-fructose (HFF)
3 Ibervillea sonorae (IS) 400
4 HFF + IS 100
5 HFF + IS 200
6 HFF + IS 400
and were conducted in compliance with the Mexican Oﬃcial
Standard(NOM—062-200-1999)technicalspeciﬁcationsfor
the production, care, and use of laboratory animals.
The animals were distributed into 6 groups of 10 animals
each and were fed a high-fat diet plus fructose (HFF). Mice
receiving the aqueous IS extract were dosed for 8 weeks in
parallel, as detailed in Table 2.
2.4. Biochemical Parameters. After eight weeks of treatment,
the animals were fasted for 8 hours and then sacriﬁced.
Blood was collected by retroorbital puncture, and serum
was prepared by centrifuging the blood at 3000rpm for
20 minutes. The levels of serum glucose, total cholesterol
(TC), HDL cholesterol (HDL-C), and triglycerides (TGs)
were determined to analyse using the automatic Selectra
analyser (Modelo Vitalab 2), with commercial kits (RAN-
DOX). The Friedewald formula [22] was used to calculate
serum low-density lipoprotein cholesterol (LDL-C) values
and atherogenic index as follows: LDL-C = TC-(HDL-C +
TG/5); atherogenic index = (TC-HDL-C)/HDL-C. The liver
and periepididymal fat were also weighed.
2.5. Hepatic Lipid Peroxidation Assay. The hepatic weight
was recorded and lipid peroxidation assessed by measuring
malondialdehyde (MDA) content as described by Buege and
Aust [23], with minor modiﬁcations. Brieﬂy, 50mg liver
was homogenised in 0.5mL cold phosphate buﬀer (pH 7.0),
followed immediately with the addition of 1mL of a reagent
containing trichloroacetic acid (TCA), thiobarbituric acid
(TBA) and HCl (15% (w/v), 0.375% (w/v), and 0.25N,
resp.) to the homogenate. The solution was then heated
for 30min in a boiling water bath. After cooling, the
ﬂocculent precipitate was removed by centrifugation at
1000g for 10min. A Bio-Mini Shimadzu Spectrophotometer
was used to determine absorbance at 532nm. A sample
containing reagent only was used as a blank. The MDA
content was calculated using an extinction coeﬃcient of
1.56 × 10−5 M−1cm−1. The protein content was determined
using the Coomassie blue method [24], with bovine serum
albumin (BSA) as the standard.
2.6. Statistical Analysis. Data were analysed with one-way
ANOVAs followed by Holm-Sidak post hoc tests, with
signiﬁcance set to P<0.05. Food consumption was analysed
using two-way ANOVA repeated measures tests followed by
Tukey’s post hoc tests, with signiﬁcance set to P<0.05. All
analyses were performed using Sigma Stat (10.0).Journal of Biomedicine and Biotechnology 3
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Figure 1: Body weight of mice fed a high-fat diet plus fructose
(HFF) and treated with I. sonorae (IS) for 8 weeks; a: signiﬁcant
diﬀerence compared to control; b: signiﬁcant diﬀerence compared
to HFF, P<0.001 (one-way ANOVA, Holm-Sidak post hoc test,
n = 10 per group).
3. Results
3.1. Body Weight. The eﬀect of a high-fat diet plus fructose
(HFF) on the body weight of mice is shown in Figure 1.
During the 8 weeks of treatment, the weight of the HFF
groupincreasedsigniﬁcantlyfromtheﬁrstweekuntiltheend
of treatment when compared with the control group. Mice
receiving IS only (400mg/kg) underwent a 6% loss in weight
relative to the starting weight. All doses of IS (100, 200, and
400mg/kg) prevented weight gain in mice fed HFF.
3.2. Food Intake. Throughout treatment, the mice that recei-
ved the HFF diet consumed less food than the control group,
but their calorie intake was higher (Figures 2(a) and 2(b)).
Coadministration of the aqueous extract of IS reduced food
intake in all groups, with a greater eﬀect in groups treated
with 200 and 400mg/kg (Figure 2).
Compared with control-fed mice, the amount of perie-
pididymal fat was higher in mice fed the HFF diet. All
three doses of IS extract resulted in signiﬁcantly reduced fat
deposition in this region (Figure 3).
3.3. Biochemical Parameters. The HFF diet increased triglyc-
eride levels 1.9-fold (from 0.88 to 1.7mmol/L), total choles-
terol 1.8-fold (from 18.6 to 35.2mmol/L), HDL-C 2.1-fold
(from 9.5 to 20.8mmol/L), LDL-C 1.2-fold (from 11 to
13.4mmol/L), and glucose levels from 84.4 to 169.8mg/dL.
Both triglycerides and blood glucose levels in mice fed the
HFF diet were signiﬁcantly diﬀerent from mice fed with
control diet (P<0.05, Table 3).
The 400mg/kg dose of IS increased cholesterol and
LDL levels when administered alone. However, in HFF-fed
m i c e ,t r i g l y c e r i d ea n dg l u c o s el e v e l sw e r er e d u c e di nad o s e -
dependent manner by IS, with the highest dose inducing
a signiﬁcant reduction in these parameters. In control-fed
mice, IS (400mg/kg) increased the lipid proﬁle and athero-
genic index.
3.4. Hepatic Lipid Peroxidation. No signiﬁcant diﬀerences
were found in liver weight of mice fed the HFF diet and/or
treated with IS (Figure 4(a)). However, the group receiving
the HFF diet had higher levels of hepatic lipid peroxidation
than control-fed mice (Figure 4(b)). Co-administration of
200mg/kg of IS decreased oxidation levels; however, the
lower (100mg/kg) and higher (400mg/kg) doses showed no
liver protection.
4. Discussion
Fructoseisasweetenerinsugarydrinks,anditsconsumption
has increased in recent years. Sugar metabolism occurs
primarily in the liver, where a high fructose ﬂux leads to
enhanced accumulation of hepatic triglycerides, resulting in
impairedglucoseandlipidmetabolismandincreasedcardio-
vascularrisk[25–27].Dietshighinfatalsoresultinincreased
levels of blood lipids and glucose; therefore, it is proposed
that an overexpression of hepatic 1–6 bisphosphatase, which
is involved in gluconeogenesis, may be responsible for
hyperglycaemia in type II diabetes [28]. Observed increases
in body weight after consumption of a high-fat diet are
mainlyduetothehyperplasticityandhypertrophyofadipose
tissue [29]. Furthermore, studies in humans and in animal
models suggest that dietary components such as high fat and
fructose can aﬀect fatty inﬁltration and lipid peroxidation in
various diseases of the liver [30, 31]. Extensive interventions
are recommended when treating obesity and hypergly-
caemia,includingdietcontrol,exercise,andpharmacological
interventions. However, many patients do not respond to
treatment and may present with adverse treatment eﬀects,
indicating a need for eﬃcacious alternatives. Some plants
contain active substances with important pharmacological
activities, and they represent an excellent alternative. In the
murine model used in this study, we found the expected
HFF-induced increase in body weight and periepididymal
fat as well as hyperglycaemia and hypertriglyceridemia. IS
treatment prevented these alterations, suggesting that the
aqueous extract of IS exhibits pharmacological antiobesity
eﬀects. Our results show that the HFF diet increased body
weightinmice,eventhoughfoodintakewaslowercompared
with the control diet. The HFF diet provides more calories
than a normal diet, resulting in a high level of fat storage
in the periepididymal region. IS administration prevented
weight gain and reduced the consumption of food and
calories in HFF-fed mice. However, 400mg/kg IS aqueous
extract alone reduced food intake and caused weight loss in
mice.Thiscouldbeatoxiceﬀectinnormalmicefedanormal
diet, but this eﬀect had not been reported before.
The HFF diet increased cholesterol, triglycerides, and
blood glucose levels, as well as HDL-C, suggesting that
the HFF diet is not atherogenic. Co-administration of IS
extract, at 400mg/kg, reduced triglycerides, cholesterol, and
glycaemia levels, but lower doses did not show a similar
activity. IS aqueous extract alone (400mg/kg) increased
triglycerides, cholesterol, and LDL-C but decreased HDL-C,
which suggests an atherogenic eﬀect in normal mice; a result
not reported previously. Andrade-Cetto and Heinrich [18]
and Alarcon-Aguilar et al. [32] reported that aqueous and4 Journal of Biomedicine and Biotechnology
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Figure 2: Food and calorie consumption (kcal) in mice fed a high-fat diet plus fructose (HFF) and treated with I. sonorae (IS) for 8 weeks;
a: signiﬁcant diﬀerence compared to control; b: signiﬁcant diﬀerence compared to HFF, P<0.05 (one-way ANOVA, Tukey’s post hoc test).
Table 3: Glycaemia and lipid proﬁle in male mice fed HFF and/or IS for 8 weeks.
Control IS 400mg/kg HFF HFF + IS 100mg/kg HFF + IS 200mg/kg HFF + IS 400mg/kg
Triglycerides (mmol/L) 0.9 ± 0.05 1.15 ± 0.2a 1.7 ± 0.2a 1.36 ± 0.2 1.2 ± 0.11 0.96 ± 0.11b
Cholesterol (mmol/L) 18.6 ± 0.4 29 ± 2.2a 35 ± 2.8a 38.8 ± 3.8a 32.3 ± 3.8a 28.4 ± 1.4b
HDL-C (mmol/L) 9.5 ± 0.6 7.7 ± 1.6b 20.8 ± 1.4a 16.4 ± 1.7a 16.1 ± 0.5a 16.4 ± 1.4a
LDL-C (mmol/L) 12.1 ± 1.7 21.8 ± 6.1a 15.0 ± 3.2 23.1 ± 4.5a 16.7 ± 0.01 12.40 ± 1.4
Glycaemia (mg/dL) 84.4 ± 6.7 96 ± 7.1 169.8 ± 13.9a 141 ± 21.4a 128.3 ± 13.2a 91.8 ± 7.1b
Atherogenic index 0.9 ± 0.2 2.8 ± 1.1a 0.7 ± 0.9 1.4 ± 0.7 1.0 ± 0.09 0.7 ± 1.2
Data are mean ± S.E. HFF: high fat and fructose; IS: Ibervillea sonorae; a: signiﬁcant diﬀerence compared to Control; b: signiﬁcant diﬀerence compared to
HFF, P<0.05 (one-way ANOVA, Tukey’s post hoc test).
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Figure 3:Periepididymalfatinmicefedcontroldiet,orHFFand/or
IS for 8 weeks; a: signiﬁcant diﬀerence compared to control; b:
signiﬁcantdiﬀerencecomparedtoHFF,P<0.05(one-wayANOVA,
Tukey’s post hoc test).
dichloromethane extracted IS reduced blood glucose levels
signiﬁcantly in mice with alloxan-induced diabetes. The
authors suggested that the hypoglycaemic eﬀect may have
been due to an improvement in insulin sensitivity and/or
reduced insulin resistance. However, functional pancreatic β
cells were required to achieve these eﬀects, which suggests
a potential therapeutic use of IS for type II diabetes. As
observed in results from the liver TBARS assay, our data
showed increased hepatic lipid peroxidation in the HFF-
fed group. These results indicated that eight weeks of HFF
diet induced oxidative stress that could damage the liver.
IS extract dosed at 200mg/kg reduced hepatic oxidation in
HFF-fed mice, while lower and higher doses had no eﬀect.
The antiobesity eﬀects of IS have not been reported
previously. Although the mechanism of action of IS is not
clearly established, it has been proposed to result from
constituents such as saponins and ﬂavonoids [33]. Studies
using other plants of the same family, such as Momordica
charantia (MC), have suggested that the blood-glucose-
lowering eﬀect of IS is through inhibition of glucose uptake,
facilitation of glucose entrance into skeletal muscle cells,
and increased insulin sensitivity. We also observed a lipid-
lowering eﬀect in HFF-fed mice, and this was mainly
attributed to saponins present in the aqueous extract [34,
35]. Other authors also reported that fractions of MC
inhibited disaccharidase, which had a marked inﬂuence on
carbohydrate absorption and inhibited elevation of blood
glucose. These results suggest that the main constituentJournal of Biomedicine and Biotechnology 5
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Figure 4: (a) Weight and (b) lipid peroxidation levels in liver
of mice fed a high-fat diet plus fructose (HFF) and treated with
I. sonorae (IS) for 8 weeks; a: signiﬁcant diﬀerence compared to
Control; b: signiﬁcant diﬀerence compared to HFF, P<0.05 (one
way ANOVA, Tukey’s post hoc test).
of MC that underlies its hypoglycaemic eﬀect could also
inhibit pancreatic lipase and, consequently, the intestinal
absorption of lipids thus contributes to the hypolipidemic
and antiobesity properties of MC [34]. Because IS belongs
to the same family as MC, it is expected to have similar
constituents that could contribute to its activity. Hern´ andez-
Galicia et al. [21] reported that dichloromethane-extracted
IS contained monoglycerides with antioxidant eﬀects, which
was observed only with the dose of 200mg/kg, in our study.
In conclusion, a HFF diet increased weight gain, choles-
terol, triglycerides, blood glucose levels, and hepatic lipid
peroxidation in mice. Aqueous extracts of IS (400mg/kg)
exhibited antiobesity eﬀects and reduced glycaemia and
hypotriglyceridemic eﬀects in HFF-diet-induced obese and
hyperglycaemic mice. The IS extract alone, at 400mg/kg,
decreased body weight and increased the atherogenic index.
However, further investigations are required to assess the
possible toxicity of Ibervillea sonorae.
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